MRSN

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Mersana Therapeutics Inc

NASDAQ | MRSN

9.91

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$46.11M

Market Cap

-

P/E Ratio

-14.79

EPS

$70.75

52 Week High

$5.21

52 Week Low

HEALTHCARE

Sector

MRSN Chart

Recent Chart
Price Action

MRSN Technicals

Tags:

MRSN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $39M
Total Revenue $40M
Cost Of Revenue $1.6M
Costof Goods And Services Sold $1.6M
Operating Income -$73M
Selling General And Administrative $41M
Research And Development $73M
Operating Expenses $114M
Investment Income Net -
Net Interest Income $4.6M
Interest Income $8.4M
Interest Expense $3.9M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$69M
Income Tax Expense $418K
Interest And Debt Expense -
Net Income From Continuing Operations -$69M
Comprehensive Income Net Of Tax -
Ebit -$65M
Ebitda -$63M
Net Income -$69M

Revenue & Profitability

Earnings Performance

MRSN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $145M
Total Current Assets $137M
Cash And Cash Equivalents At Carrying Value $108M
Cash And Short Term Investments $108M
Inventory -
Current Net Receivables -
Total Non Current Assets $7.8M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $27M
Other Current Assets $2.3M
Other Non Current Assets -
Total Liabilities $154M
Total Current Liabilities $62M
Current Accounts Payable $4.3M
Deferred Revenue -
Current Debt -
Short Term Debt $16M
Total Non Current Liabilities $92M
Capital Lease Obligations $5.1M
Long Term Debt $11M
Current Long Term Debt $13M
Long Term Debt Noncurrent -
Short Long Term Debt Total $29M
Other Current Liabilities $20M
Other Non Current Liabilities $8K
Total Shareholder Equity -$9.5M
Treasury Stock -
Retained Earnings -$896M
Common Stock $12K
Common Stock Shares Outstanding $4.9M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$82M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.6M
Capital Expenditures $132K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $11M
Cashflow From Financing $4.1M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $486K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$69M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $39M
Total Revenue $40M
Cost Of Revenue $1.6M
Costof Goods And Services Sold $1.6M
Operating Income -$73M
Selling General And Administrative $41M
Research And Development $73M
Operating Expenses $114M
Investment Income Net -
Net Interest Income $4.6M
Interest Income $8.4M
Interest Expense $3.9M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$69M
Income Tax Expense $418K
Interest And Debt Expense -
Net Income From Continuing Operations -$69M
Comprehensive Income Net Of Tax -
Ebit -$65M
Ebitda -$63M
Net Income -$69M

MRSN News

MRSN Profile

Mersana Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in the development of innovative Antibody Drug Conjugates (ADCs) aimed at addressing unmet medical needs in oncology. With a focus on delivering targeted therapies that improve patient outcomes, Mersana is advancing a robust pipeline of ADCs that leverage its proprietary technology platform. Committed to transforming cancer treatment, the company is poised to make significant contributions to the field as it progresses through clinical trials and partners with leading organizations in the biopharmaceutical industry.

VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
STAI
+39.44%
$0.62
BURU
+7.15%
$0.50
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+118.14%
$9.07
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+2.94%
$16.76
DNN
+7.11%
$3.08
EPWK
-21.60%
$0.09
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
F
+1.18%
$11.54
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
PFE
-1.82%
$24.78
CRML
+55.40%
$23.28
TSLA
+5.01%
$434.23
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
ETHD
-12.95%
$3.32
RXRX
+3.94%
$5.53
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
QUBT
-10.81%
$19.01
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
USAR
+18.61%
$38.68
MP
+21.94%
$95.52
BTBT
+5.58%
$3.97
IREN
+7.31%
$64.14
NAKA
-1.56%
$0.85
RIG
+3.73%
$3.19
WBD
-3.22%
$17.10
UAMY
+36.85%
$16.71
NOK
-1.50%
$5.24
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.14%
$25.57
RF
+1.63%
$24.55
SRM
+53.27%
$10.30
GDXD
-13.54%
$0.73
IONQ
+18.72%
$83.88
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
BMNR
+7.40%
$56.35
CLF
-7.18%
$13.18
VALE
+2.37%
$11.00
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RGTZ
-50.00%
$9.30
SLB
+1.71%
$32.26
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
STAI
+39.44%
$0.62
BURU
+7.15%
$0.50
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+118.14%
$9.07
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+2.94%
$16.76
DNN
+7.11%
$3.08
EPWK
-21.60%
$0.09
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
F
+1.18%
$11.54
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
PFE
-1.82%
$24.78
CRML
+55.40%
$23.28
TSLA
+5.01%
$434.23
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
ETHD
-12.95%
$3.32
RXRX
+3.94%
$5.53
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
QUBT
-10.81%
$19.01
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
USAR
+18.61%
$38.68
MP
+21.94%
$95.52
BTBT
+5.58%
$3.97
IREN
+7.31%
$64.14
NAKA
-1.56%
$0.85
RIG
+3.73%
$3.19
WBD
-3.22%
$17.10
UAMY
+36.85%
$16.71
NOK
-1.50%
$5.24
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.14%
$25.57
RF
+1.63%
$24.55
SRM
+53.27%
$10.30
GDXD
-13.54%
$0.73
IONQ
+18.72%
$83.88
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
BMNR
+7.40%
$56.35
CLF
-7.18%
$13.18
VALE
+2.37%
$11.00
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RGTZ
-50.00%
$9.30
SLB
+1.71%
$32.26
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.